DOCSLIB.ORG

2003 Conferenceprogram.Qxd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2003 Conferenceprogram.Qxd Funded by the National Institute on Drug Abuse Third National Conference Stress and Addiction: From Molecule to Neighborhood Wyndham Miami Beach Resort 4833 Collins Avenue Miami Beach, FL 33140 October 2-4, 2003 Funded by the National Institute on Drug Abuse Third National Conference Stress and Addiction: From Molecule to Neighborhood Wyndham Miami Beach Resort 4833 Collins Avenue Miami Beach, FL 33140 October 2-4, 2003 National Hispanic Science Network on Drug Abuse Mission Statement he National Hispanic Science Network on TDrug Abuse is dedicated to improving the health of Hispanics by: 1) Increasing the amount and quality of interdisciplinary translational research on drug abuse; and, 2) Fostering the development of Hispanic scientists in drug abuse research. 2 National Steering Committee José Szapocznik, Ph.D. Patricia Molina, M.D., Ph.D. Chair, NHSN Associate Professor Professor & Director Department of Psychology Center for Family Studies Louisiana State University Department of Psychiatry & Behavioral Sciences University of Miami School of Medicine J. Bryan Page, Ph.D. Professor and Chair Hortensia Amaro, Ph.D. Department of Anthropology Distinguished Professor & Director University of Miami Institute on Urban Health Research Bouvé College of Health Sciences Northeastern University Rafaela R. Robles, Ed.D. Professor Department of Community Health Ana Mari Cauce, Ph.D. Universidad Central del Caribe Professor and Chair Department of Psychology University of Washington Daniel Santisteban, Ph.D. Associate Professor Department of Psychiatry & Behavioral Sciences Alexander Kopelowicz, M.D. University of Miami School of Medicine Associate Professor Department of Psychiatry University of California at Los Angeles Avelardo Valdéz, Ph.D. Professor Graduate School of Social Work Joe L. Martínez, Ph.D. University of Houston Ewing Halsell Professor of Neuroscience Department of Biology University of Texas at San Antonio William A. Vega, Ph.D. Professor Department of Psychiatry UMDNJ/ Robert Wood Johnson Medical School 3 Thursday, October 2, 2003 Scientific Program 8:00 a.m. - 5:30 p.m. Registration Grand Promenade Foyer, Lobby Level 12:00 p.m. - 1:30 p.m. Opening Luncheon Grand Promenade Room, Lobby Level Welcoming José Szapocznik, Ph.D. Remarks: Chair, NHSN University of Miami School of Medicine Ana Anders, L.I.C.S.W. Senior Advisor, Special Populations Office National Institute on Drug Abuse Conference William A. Vega, Ph.D. Overview: Chair, NHSN 2003 Conference Planning Subcommittee UMDNJ/ Robert Wood Johnson Medical School Featured Andrea Barthwell, M.D., F.A.S.A.M. Speaker: Deputy Director for Demand Reduction White House Office of National Drug Control Policy 1:30 p.m. - 1:45 p.m. BREAK *** All presentations in Regency Ballroom, Lobby Level*** 1:45 p.m. - 3:30 p.m. Putative Social and Biologic Mechanisms Affecting the Stress Relationship to Drug Abuse Chair & Joe L. Martínez, Ph.D. Discussant: University of Texas at San Antonio Presenters: Patricia Molina, M.D., Ph.D. Louisiana State University “Neurobiology of the Stress Response” William A. Vega, Ph.D. UMDNJ/ Robert Wood Johnson Medical School “Stress and Cultural Adaptation: Why are Latino Drug Use Rates Higher in the U.S. than in Nations of Origin?” Avelardo Valdéz, Ph.D. University of Houston “Social Capital, Substance Use and Stress” 4 Thursday, October 2, 2003 Scientific Program 3:30 p.m. - 3:45 p.m. BREAK 3:45 p.m. - 5:30 p.m. Predisposing Factors and Neurobiologic Substrates Chair & George A. Ricaurte, M.D., Ph.D. Discussant: Johns Hopkins University Presenters: Jon Kar Zubieta, Ph.D. University of Michigan “Brain Circuits in Addiction“ Kathleen Ries Merikangas, Ph.D. National Institute of Mental Health ”Migrant Study of Substance Use Disorders in Puerto Rican Families“ María Elena Medina-Mora, Ph.D. National Institute of Psychiatry of Mexico “Differences in U.S.-Mexico Drug Use Patterns Based on the Results of the National Household Surveys on Addictions and Other Studies” 5:30 p.m. Adjourn Scientific Program 5:30 p.m. - 6:00 p.m. NHSN Membership Photo Session Grand Promenade Room, Lobby Level All NHSN Scientist and Student Members, please proceed to the Grand Promenade Room where group photographs will be taken. 6:00 p.m. - 7:00 p.m. BREAK 7:00 p.m. - 9:00 p.m. Dinner and Awards Ceremony Starlight Ballroom, 18th Floor Hortensia Amaro, Ph.D. Northeastern University William A. Vega, Ph.D. UMDNJ/ Robert Wood Johnson Medical School 9:00 p.m. - 11:00 p.m. Social Event Starlight Ballroom, 18th Floor 5 Friday, October 3, 2003 Scientific Program 8:00 a.m. - 9:00 a.m. Breakfast Grand Promenade Room, Lobby Level 8:00 a.m. - 5:30 p.m. Registration Grand Promenade Foyer, Lobby Level 8:00 a.m. - 5:30 p.m. Poster Session Mediterranean Room Center, Lobby Level Posters available for viewing all day. See pages 12 & 13 for Poster titles and authors. *** All presentations in Regency Ballroom, Lobby Level*** 9:00 a.m. - 10:00 a.m. Keynote Address Nora Volkow, M.D. Director, National Institute on Drug Abuse 10:00 a.m. - 10:15 a.m. BREAK 10:15 a.m. - 12:15 p.m. Prevention Science: Cultural Relevance from Molecular Mechanisms to Community Interventions Chair & Felipe González-Castro, Ph.D. Discussant: Arizona State University Presenters: William A. Carlezon, Ph.D. Harvard University “Biological Mechanisms of Aversive States in Drug Addiction” Hilda Pantín, Ph.D. University of Miami School of Medicine “Familias Unidas: A Preventive Intervention for Latino Adolescents and Families in Urban Environments” Charles Martínez, Ph.D. Oregon Social Learning Center “Adapting Preventive Intervention Models for Communities Undergoing Rapid Sociodemographic Shifts” 12:15 p.m. - 1:45 p.m. Mentoring Luncheon Grand Promenade Room, Lobby Level Seating for the Mentoring Luncheon has been pre-arranged based on information provided by the conference participants. Please refer to the seating chart in your registration packet for your assigned table. 6 Friday, October 3, 2003 Scientific Program 1:45 p.m. - 2:00 p.m. BREAK 2:00 p.m. - 4:00 p.m. Multiple Levels of Intervention Targets in Addiction Treatment and Relapse Prevention Chair & Daniel Santisteban, Ph.D. Discussant: University of Miami School of Medicine Presenters: Diana Martínez, M.D. Columbia University “Imaging the Neurobiology of Addiction” Hortensia Amaro, Ph.D. Northeastern University “Treatment Retention Among Hispanic Women: Findings and Questions for Future Research” Rafaela R. Robles, Ed.D. Universidad Central del Caribe “Effects of a Two-Facet Intervention to Reduce HIV Risk Behaviors Among Hispanic Drug Injectors in Puerto Rico: A Randomized Controlled Study” 4:00 p.m. Adjourn Scientific Program 4:00 p.m. - 5:30 p.m. Poster Session and Reception Mediterranean Room Center, Lobby Level Chair: Charles Martínez, Ph.D. Oregon Social Learning Center Co-Chair: Steve R. López, Ph.D. University of California at Los Angeles See pages 12 & 13 for Poster titles and authors. 7 Saturday, October 4, 2003 8:00 a.m. - 9:00 a.m. Breakfast Grand Promenade Room, Lobby Level 9:00 a.m. - 10:30 a.m. National Network Meeting: National Strategic Plan on Hispanic Drug Abuse Research Chair: Hortensia Amaro, Ph.D. Northeastern University 10:30 a.m. - 10:45 a.m. BREAK 10:45 a.m. - 12:00 p.m National Network Meeting: National Strategic Plan (Continued) 12:00 p.m - 12:45 p.m. Working Lunch - National Network Meeting: National Strategic Plan 12:45 p.m. Adjourn National Network Meeting 12:45 p.m. - 1:00 p.m. BREAK 1:00 p.m. - 3:00 p.m. Research Funding and Career Development Workshop Co-Chair: Angela Pattatucci-Aragón, Ph.D. University of Puerto Rico Co-Chair: Iván Montoya, M.D., M.P.H. National Institute on Drug Abuse New Funding Priorities and Initiatives Chair: Iván Montoya, M.D., M.P.H. National Institute on Drug Abuse Panelists: Jerry Flanzer, D.S.W. National Institute on Drug Abuse Eleanor McLellan-Lemal, M.A. Centers for Disease Control and Prevention Susan F. Newcomer, Ph.D. National Institute of Child Health & Human Development Tracy Enright Patterson, M.A. Wake Forest University School of Medicine Robert Wood Johnson Foundation Mónica S. Ruiz, Ph.D., M.P.H. National Institute of Allergy and Infectious Diseases 8 Saturday, October 4, 2003 3:00 p.m. - 3:15 p.m. BREAK 3:15 p.m. - 5:00 p.m. Research Funding and Career Development Workshop (Continued) Grant Review and Grant Post-Submission Issues Panel Chair: Eduardo Montalvo, Ph.D. Center for Scientific Review National Institutes of Health Panelists: Alexander N. Ortega, Ph.D., M.P.H. Ohio State University Jesús Ramírez Vallez, Ph.D. University of Illinois Mildred Vera, Ph.D. University of Puerto Rico María Cecilia Zea, Ph.D. George Washington University 5:00 p.m. Adjourn Research Funding and Career Development Workshop 9 ABSTRACTS Putative Social and Biologic Mechanisms Affecting the Stress Relationship to Drug Abuse Chair & Discussant: Joe L. Martínez, Jr., Ph.D. University of Texas at San Antonio Stress contributes to drug abuse in at least two ways: by influencing brain function directly, and through psychological mediation. Patricia E. Molina, M.D., Ph.D., will review evidence indicating that physical and psychological stress is associated with a higher incidence of drug abuse. In particular, the hippocampus is a sensitive target for the damage produced by the stress response. The challenge remains to understand how this structure may contribute to drug abuse in vulnerable individuals. Avelardo Valdéz, Ph.D., will illustrate how a measure of social capital may mediate the relationship of stress as an antecedent to substance use and other risk behaviors. William Vega, Ph.D., will review evidence for a "Hispanic paradox" in drug abuse, including epidemiologic findings that support a social stress and social assimilation explanation. Risk factors for immigrants and U.S.-born Latinos will be examined.
Load more

Recommended publications
  • 2015 Annual Conference & Hill
    LEARN CONNECT ADVOCATE SUCCEED Welcome to Washington, D.C. and the 2015 Annual Conference & Hill Day October 9 – 13 Washington, D.C. Bethesda North Marriott Hotel & Conference Center MATHISWORKS & SEAMARTINI | PHOTOSPIN.COM Visit booth 105 vivitrol.com/hcp VIVITROL is a registered trademark of Alkermes, Inc. ©2014 Alkermes, Inc. All rights reserved VIV-001684 Printed in U.S.A. vivitrol.com CONTENTS WELCOME Schedule at a Glance 4 Welcome to the NAADAC Annual Conference & Hill Day! As NAADAC President, I, and the Mid-Atlantic Affiliates, welcome you to the 2015 NAADAC Annual Business Meetings 5 Conference & Hill Day, Learn Connect Advocate Succeed. We are thrilled to be hold ing our General Information 7 conference in Washington, D.C. and combining our Advocacy and Annual Conferences into this special event. Download the 2015 Conference App 7 This conference not only includes a strong lineup of keynote and plenary speakers, but also a mul- Continuing Education 8 titude of workshops with the latest information on the trends and issues that impact all addiction- Thank You to All of Our Sponsors, 9 focused professionals. In addition, on Tuesday, October 13, 2015, NAADAC members and other Exhibitors, and Partners addiction-focused professionals from across the country will participate in a special Advocacy in Action briefing and then convene on Capitol Hill to meet with their congressional representatives Daily Schedule 10 to advocate for the addiction profession. Presenter Biographies 27 The conference isn’t all about learning, however. It is also about networking and having fun. As in The Exhibitors 39 the past, we will be recognizing contributions to the addiction profession and outstanding achieve- ment efforts at our awards luncheon.
    [Show full text]
  • The 6Th Annual
    JULY 15-18, 2018 OMNI AMELIA ISLAND PLANTATION RESORT AMELIA ISLAND, FLORIDA Onsite Program Supported by The 6th Annual Recovery Experience COREClinical Overview of the Hosted by In Collaboration with Scan the QR Code below to download our app • Earn up to 25 HOURS of Continuing Education • Choose from 30 challenging workshops One call is all it takes. We are committed to working with you to get your clients into treatment as quickly and easily as possible. From admissions paperwork to transportation, our consultants will manage the entire process for you, keeping you informed every step of the way. Our full spectrum of addiction treatment services, emphasis on dual-diagnosis, and multitude of locations nationwide mean that we have a program to fit the unique needs of each of your clients. American Addiction Centers is a leading provider of inpatient substance abuse treatment services. We treat adults who are struggling with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues. With coast-to-coast facilities and caring, highly-seasoned professionals, American Addiction Centers is your ideal treatment partner. One call is all it takes. 866.537.6237 Learn More About How We Can Help. CALL 866.537.6237 Consultants Available 24/7 americanaddictioncenters.org americanaddictioncenters.org One call is all it takes. We are committed to working with you to get your clients into treatment as quickly and easily as possible. From admissions paperwork to transportation, our consultants will manage the entire process for you, keeping you informed every step of the way. Our full spectrum of addiction treatment services, emphasis on dual-diagnosis, and multitude of locations nationwide mean that we have a program to fit the unique needs of each of your clients.
    [Show full text]
  • Confirmation Hearing on the Nomination of John P
    S. HRG. 107–632 CONFIRMATION HEARING ON THE NOMINATION OF JOHN P. WALTERS TO BE DIRECTOR OF THE OFFICE OF NATIONAL DRUG CONTROL POLICY HEARING BEFORE THE COMMITTEE ON THE JUDICIARY UNITED STATES SENATE ONE HUNDRED SEVENTH CONGRESS FIRST SESSION OCTOBER 10, 2001 Serial No. J–107–42 Printed for the use of the Committee on the Judiciary ( U.S. GOVERNMENT PRINTING OFFICE 81–443 PDF WASHINGTON : 2002 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2250 Mail: Stop SSOP, Washington, DC 20402–0001 VerDate Feb 1 2002 13:39 Sep 13, 2002 Jkt 000000 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 C:\HEARINGS\81443.TXT SJUD4 PsN: CMORC COMMITTEE ON THE JUDICIARY PATRICK J. LEAHY, Vermont, Chairman EDWARD M. KENNEDY, Massachusetts ORRIN G. HATCH, Utah JOSEPH R. BIDEN, JR., Delaware STROM THURMOND, South Carolina HERBERT KOHL, Wisconsin CHARLES E. GRASSLEY, Iowa DIANNE FEINSTEIN, California ARLEN SPECTER, Pennsylvania RUSSELL D. FEINGOLD, Wisconsin JON KYL, Arizona CHARLES E. SCHUMER, New York MIKE DEWINE, Ohio RICHARD J. DURBIN, Illinois JEFF SESSIONS, Alabama MARIA CANTWELL, Washington SAM BROWNBACK, Kansas JOHN EDWARDS, North Carolina MITCH MCCONNELL, Kentucky BRUCE A. COHEN, Majority Chief Counsel and Staff Director SHARON PROST, Minority Chief Counsel MAKAN DELRAHIM, Minority Staff Director (II) VerDate Feb 1 2002 13:39 Sep 13, 2002 Jkt 000000 PO 00000 Frm 00002 Fmt 5904 Sfmt 5904 C:\HEARINGS\81443.TXT SJUD4 PsN: CMORC C O N T E N T S STATEMENTS OF COMMITTEE MEMBERS Page Biden, Hon.
    [Show full text]
  • New President Says ASAM Has ·-~ ~ "Talent, Energy, Experience" to Mee1t Chal1enges G
    Newsletter 0 f The American Society' of Addictionr, Medicine ' .- ' ; New President Says ASAM Has ·-~ ~ "Talent, Energy, Experience" to Mee1t Chal1enges G. Douglas Talbott, M.D. , FASAM I assume the Presidency of ASAM with hu­ AMA's Physicians Health Committee. I sub­ The Caduceus Foundation also has convened mility, excitement and a sense of exultation. sequently approached Drs. Gitlow and a number of expert meetings on caffeine, Seixas and the basis of the first Kroc Ranch chaired by Dr. Max Schneider. The findings To follow Dr. David Smith's Presidency is unity meeting was established. from these sessionii.were reported at the 1993 by definition a humbling experience. It is Medical-Scientific Conference in a sympo­ also humbling to be elected President of sium on the role of caffeine in addiction ASAM, for this is truly a great and unique treatment. organization. I exult in the richness of this history, and in Nor can I assume the presidency of this or­ the current accomplishments represented by ganization without exultation. I have been the ASAM Patient Placement Criteria un­ with ASAM from the birth of the Southeast­ der the leadership of Dr. David Mee-Lee and ern addiction movement, the California the efforts on tobacco, led by Dr. John Slade. movement, and the New York movement. The New York programs were much older Goals for the Future than the California and Georgia programs, As we look toward the future, I want to but I learned of the New York program dedicate my presidency to the establish­ through the work of Drs. Frank Seixas, ment of residencies in addiction medicine Sheila Blume, Stan Gitlow, and through my in a number of university medical centers.
    [Show full text]
  • Spons Agency Available from Abstract Document
    DOCUMENT RESUME ED 427 109 UD 032 752 TITLE Treatment for Addiction: Advancing the Common Good. Recommendations from a Join Together Policy Panel on Treatment and Recovery. INSTITUTION Join Together, Boston, MA. SPONS AGENCY Robert Wood Johnson Foundation, Princeton, NJ. PUB DATE 1998-00-00 NOTE 43p. AVAILABLE FROM Join Together, 441 Stuart Street, 7th Floor, Boston, MA 02116; Tel: 617-437-1500; Fax: 617-437-9394; e-mail: [email protected]; Web site: www.jointogether.org ($5). PUB TYPE Guides Non-Classroom (055) EDRS PRICE MF01/PCO2 Plus Postage. DESCRIPTORS *Community Programs; Delivery Systems; *Health Education; Health Insurance; Integrated Activities; Law Enforcement; *Policy Formation; Public Policy; *Substance Abuse; *Therapy IDENTIFIERS *Addictive Behavior ABSTRACT Join Together convened a panel of experts to review U.S. policies for addiction treatment and recovery. Although the panel reached an agreement on six recommendations for policy changes that can make help more accessible and expand treatment to more people. These recommendations are: (1) treatment for alcoholism and other drug addiction must be covered as a health benefit on an equal basis with treatment for other diseases; (2) limited access to treatment for alcoholism and drug addiction is a national crisis that calls for a broad-based national campaign to educate the public and build political support;(3) research on the nature and treatment of addiction and recovery should be expanded and the results made accessible to professionals, policymakers, and the public;(4) education and training on addiction and recovery should be required for all health, mental health, social service, and justice system professionals;(5) treatment for alcoholism and drug addiction must be monitored by independent treatment managers with no vested financial interests in order to ensure ongoing treatment effectiveness; and (6) diagnosis, treatment, and long-term recovery must be integrated into a coordinated community-wide strategy to reduce alcohol and other drug problems.
    [Show full text]
  • Women Who Made a Difference
    White, W. (2004). Women who made (and are making) a difference. Counselor, 5(5), 25-29. Women Who Made (and are Making) a Difference William L. White When I entered the field of addiction treatment in the 1960s, it was a man’s world, and it had been a man’s world for more than 175 years. It was a professional arena dominated by male service consumers, male service providers, male administrators, and male policy makers. Women filling such roles were an anomaly, not the norm. That world changed because women pioneers made significant contributions to the history of the addiction treatment field. The purpose of this article is to honor a few of these pioneers who made, and are making, a difference through their research, clinical innovation, public and professional education, public policy advocacy and through their philanthropy. Here are more than sixty women who made and are making a difference in the addiction treatment and recovery arena. Dr. Andrea Barthwell has served as the Deputy Director of Demand Reduction in the White House Office of National Drug Control Policy. Before assuming this position, she served as medical director of several addiction treatment programs and as president of the board of the American Society of Addiction Medicine. Dr. Barthwell is a passionate and articulate advocate for enhanced accessibility and quality of addiction treatment. Dr. LeClair Bissell is one of the modern pioneers of addiction medicine and the broader field of addiction treatment. Her contributions to the field are reflected in awards from the American Society on Addiction Medicine and the Christopher D.
    [Show full text]
  • September 2002
    NIDA - Director's Report - September 2002 Home > Publications > Director's Reports Director's Report to the National Advisory Council on Drug Abuse - September, 2002 Index Report Index Research Findings Report for May, 2002 Basic Research Report for February, Behavioral Research 2002 Treatment Research and Development Report for Research on AIDS and Other Medical Consequences of Drug September, 2001 Abuse Report for May, Epidemiology, Etiology and Prevention Research 2001 Services Research Report for February, 2001 Intramural Research Report for Program Activities September, 2000 Report for May, Extramural Policy and Review Activities 2000 Report for February, Congressional Affairs 2000 Report for International Activities September, 1999 Report for May, Meetings and Conferences 1999 Report for February, Media and Education Activities 1999 Report for Planned Meetings September, 1998 Report for May, Publications 1998 Report for February, Staff Highlights 1998 Report for Grantee Honors September, 1997 Report for May, 1997 Report for February, 1997 Report from September, 1996 Report from May, 1996 Report from February, 1996 Report from September, 1995 Report from May, 1995 https://archives.drugabuse.gov/DirReports/DirRep902/Default.html[11/17/16, 10:05:16 PM] NIDA - Director's Report - September 2002 Report from February, 1995 NACDA Legislation Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S.
    [Show full text]
  • EDGAR Submission Header Summary
    EDGAR Submission Header Summary Submission Type 424B4 Live File on Return Copy on Submission Contact RDG Filings Submission Contact Phone Number 1-415-643-6080 Exchange NASD Confirming Copy off Filer CIK 0001136174 Filer CCC xxxxxxxx Filer File Number 333-173659 Serial off Fee Table In Prospectus off Notify via Filing website Only off Emails [email protected] Documents 424B4 catasys_424b4-122011.htm Form 424(b)(4) GRAPHIC logo.jpg Module and Segment References Filed pursuant to Rule 424(b)(4) File number 333-173659 PROSPECTUS 11,000,000 Shares of Common Stock and Warrants to Purchase up to 11,000,000 Shares of Common Stock We are offering up to 11,000,000 shares of our common stock and warrants to purchase up to 11,000,000 shares of our common stock. All purchasers will receive five-year warrants to purchase an aggregate of up to 11,000,000 shares of common stock at an exercise price of $0.30 per share. Each purchaser will receive a unit consisting of a share of common stock and warrants to purchase our common stock. We are not required to sell any specific dollar amount or number of shares of common stock or warrants, but will use our best efforts to sell all of the shares of common stock and warrants being offered. The offering expires on the earlier of (i) the date upon which all of the shares of common stock and warrants being offered have been sold, or (ii) January 1, 2012. Our common stock is traded on the Pink Sheets under the symbol “CATS.PK”.
    [Show full text]
  • Selected Papers of William L. White
    Selected Papers of William L. White www.williamwhitepapers.com Collected papers, interviews, video presentations, photos, and archival documents on the history of addiction treatment and recovery in America. Citation: White, W. (2004). Women who made (and are making) a difference. Counselor, 5(5), 25-29. Posted at www.williamwhitepapers.com Women Who Made (and are Making) a Difference William L. White Emeritus Senior Research Consultant Chestnut Health Systems [email protected] When I entered the field of addiction is a passionate and articulate advocate for treatment in the 1960s, it was a man’s world, enhanced accessibility and quality of and it had been a man’s world for more than addiction treatment. 175 years. It was a professional arena Dr. LeClair Bissell is one of the dominated by male service consumers, male modern pioneers of addiction medicine and service providers, male administrators, and the broader field of addiction treatment. Her male policy makers. Women filling such contributions to the field are reflected in roles were an anomaly, not the norm. That awards from the American Society on world changed because women pioneers Addiction Medicine and the Christopher D. made significant contributions to the history Smithers Foundation. Her publications of the addiction treatment field. The purpose include Alcoholism in the Professions (1985) of this article is to honor a few of these and Ethics for Addiction Professionals pioneers who made, and are making, a (1987). difference through their research, clinical Claudia Black, PhD, has for more innovation, public and professional than two decades given voice to the impact education, public policy advocacy and of alcoholism on children and the family.
    [Show full text]
  • National Association of Boards of Pharmacy® February 2010 / Volume 39 Number 2
    newsletter National Association of Boards of Pharmacy® February 2010 / Volume 39 Number 2 aid to government the profession JCPP ‘Future Vision’ Sets Course for Advancement the public of Pharmacy Practice 1904 to 2010 The Joint Commission been aimed to ensure of Pharmacy Practitioners public health and Upcoming (JCPP) brings together the safety by optimizing Events chief executive and chief the medication use elected officers of national process. Working col- April 13, 2010 pharmacy associations, laboratively through Committee on including NABP, to create the JCPP, leaders in Constitution and Bylaws a forum for discussion and the profession “ac- Meeting opportunity for collabora- knowledged that the April 19, 2010 tive work on issues and pri- focus of pharmacy FPGEE Administration orities of pharmacy prac- must move beyond tice. Established in 1977, the important but narrow among pharmacy organiza- May 22-25, 2010 the JCPP meets quarterly aspect of ‘right drug to the tions and other stakeholders NABP 106th Annual Meeting and forms workgroups that right patient’ and encompass have been formed, and have Hyatt Regency focus on priority projects. the responsibility for assuring helped to shape new state Orange County The JCPP has facilitated that appropriate outcomes are and national legislation and Anaheim, CA strategic planning efforts achieved when medications regulations. For example, that have shaped positive are part of a patient’s indi- JCPP coalitions helped in- July 21-22, 2010 NABP Program Review change in the practice of vidual treatment plan.” This fluence changes that resulted and Training/New pharmacy for more than perception of the function in Medicare’s prescription Executive Officers 30 years, and will continue and responsibility of pharma- drug benefit requirement for Orientation Program to influence pharmacy cy practice helped to facilitate medication therapy manage- NABP Headquarters practice through its vision changes such as the shift to ment services as of 2006.
    [Show full text]
  • 2016 CPDD Member-Retired Members Amir Abdolahi,Ph.D
    2016 CPDD Member-Retired Members Amir Abdolahi,Ph.D. Bryon H. Adinoff,M.D. 638 N. New Ballas Rd. Apt. 303 Chief, Division on Addictions Creve Coeur, MO 63141 University of Texas Southwestern Med. Ctr at Dallas Phone# (914) 261-5504 FAX# Department of Psychiatry email: [email protected] 5353 Forest Park Rd, Suite 500 Membership Status: Associate Member Dallas, TX 75390-8564 Phone# (214) 645-6975 FAX# (214) 645-6976 email: [email protected] Membership Status: Regular Member Mary E. Abood,Ph.D. Martin W. Adler,Ph.D. Associate Professor Executive Officer Temple University Temple University School of Medicine Center for Substance Abuse Research Center for Substance Abuse Research 3400 N. Broad Street 3400 N. Broad Street Philadelphia, PA 19140 Philadelphia, PA 19140-5104 Phone# (215) 707-2638 FAX# (215) 707-2966 Phone# (215) 707-3242 FAX# (215) 707-1904 email: [email protected] email: [email protected] Membership Status: Regular Member Membership Status: Charter Fellow Veronica H. Accornero,Ph.D. Arpana Agrawal,Ph.D. Assistant Professor Washington University School of Medicine 960 NE 99th Street Department of Psychiatry Miami Shores, FL 33138 660 S. Euclid, Box 8134 Phone# (305) 243-4078 FAX# (305) 243-4080 St. Louis, MO 63110 email: [email protected] Phone# (314) 286-1778 FAX# Membership Status: Associate Member email: [email protected] Membership Status: Regular Member Jane B. Acri,Ph.D. Marisela Agudelo,Ph.D. National Institute on Drug Abuse Post-Doc DPMC Florida International Univ. 6001 Executive Boulevard, Rm 4123, MSC 9551 11200 SW 8th Street Bethesda, MD 20892 Building: AHC-1, Rm #417-B Phone# (301) 443-8489 FAX# (301) 443-2599 Miami, FL 33199 email: [email protected] Phone# (305) 348-1491 FAX# (305) 348-1109 Membership Status: Regular Member email: magudelo@fiu.edu Membership Status: Associate Member Edgar H.
    [Show full text]
  • Improving Substance Abuse Treatment: the National Treatment Plan Initiative
    DOCUMENT RESUME ED 450 296 CG 030 651 TITLE Improving Substance Abuse Treatment: The National Treatment Plan Initiative. Changing the Conversation. INSTITUTION Substance Abuse and Mental Health Services Administration (DHHS/PHS), Rockville, MD. Center for Substance Abuse Treatment. REPORT NO SMA-00-3480 PUB DATE 2000-11-00 NOTE 308p. AVAILABLE FROM U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. Web site: http://www.samhsa.gov. PUB TYPE Information Analyses (070) EDRS PRICE MF01/PC13 Plus Postage. DESCRIPTORS *Certification; *Counselor Training; *Drug Education; *Labor Force; Outcomes of Treatment; *Professional Training; *Substance Abuse ABSTRACT This report is the result of five expert panels and six regional public hearings around the country that focused on key persistent issues that have characterized discussions of substance abuse over the years: closing the treatment gap; reducing stigma and changing attitudes; improving and strengthening treatment systems; connecting services and research; and addressing workforce issues. Of particular interest is the Report of Panel V: Addressing Workforce Issues. Panel V identified three types of current workforce issues: education and training; credentialing; and supply, demand, and distribution. The objective of professionals to guarantee universal delivery of optimum standards of care, together with the recent connection between provider reimbursement and education levels, calls for a formal strategy
    [Show full text]